Late‐onset cases of familial hemophagocytic lymphohistiocytosis with missense perforin gene mutations

Since the discovery of perforin gene mutations in familial hemophagocytic lymphohistiocytosis (FHL) type 2, heterogeneous features in FHL2 patients have been identified in a report of Feldmann et al. as the beginning. This study was conducted to determine the impact of characteristic gene mutations...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of hematology Vol. 82; no. 6; pp. 427 - 432
Main Authors Ueda, Ikuyo, Kurokawa, Yumi, Koike, Kenichi, Ito, Shuichi, Sakata, Akifumi, Matsumora, Tsutomu, Fukushima, Takashi, Morimoto, Akira, Ishii, Eiichi, Imashuku, Shinsaku
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.06.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Since the discovery of perforin gene mutations in familial hemophagocytic lymphohistiocytosis (FHL) type 2, heterogeneous features in FHL2 patients have been identified in a report of Feldmann et al. as the beginning. This study was conducted to determine the impact of characteristic gene mutations on late‐onset (age ≥ 7 years) hemophagocytic lymphohistiocytosis episodes. We analyzed perforin gene mutations in three late‐onset cases from our registry in Japan and an additional 10 cases from the literature. Of the 13 cases with onset ages of a median of 10 (range 7–49) years, nine had homozygous and four had compound heterozygous missense mutations of the perforin gene. None had homozygous nonsense mutations. Our data suggest that nonsense perforin gene mutations yield early onset and missense mutations late onset in FHL2 cases. Am. J. Hematol., 2007. © 2007 Wiley‐Liss, Inc.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Case Study-2
ObjectType-Feature-4
ObjectType-Report-1
ObjectType-Article-3
ISSN:0361-8609
1096-8652
DOI:10.1002/ajh.20878